<DOC>
	<DOCNO>NCT02822066</DOCNO>
	<brief_summary>The pupose study evaluate safety efficacy irreversible electroporation ( IRE ) refractory neoplasms liver pancreas , investigator use preoperative postoperative US/CEUS/CT/MRI ass lesion , laboratory test include tumor marker evaluate general condition patient . Intraoperative US/CEUS/CT would apply monitor ablation lesion .</brief_summary>
	<brief_title>Effectivity Safety Irreversible Electroporation Refractory Neoplasms Liver Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>1 . Patients hepatic portal focal lesion adjacent important structure like bile duct portal blood vessel , intolerant surgery . 2 . Patients pancreatic cancer adjacent blood vessel , intolerant surgery . Patients : 1 . Metal body 2 . ChildPugh â‰¥ 3 3 . Longterm use anticoagulant drug include warfarin , clopidogrel bisulfate 4 . Poor cardiac renal function intolerant surgery anesthesia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Effectivity</keyword>
	<keyword>safety</keyword>
	<keyword>irreversible electroporation</keyword>
	<keyword>liver</keyword>
	<keyword>pancreas</keyword>
</DOC>